Country: Israel
City: Tel Hashomer

National Hemophilia Center, Tel Hashomer
Sheba Medical Center
Tel Hashomer 52621, Israel
Tel.: 972-3-5302120; 972-3-5304981
Fax: 972 3535 1806

Director: Profs Gili Kenet
Medical Associates: Prof. Michael Heim, Prof. Uri Martinowitz, Dr Ahron Lunetsky, Dr Jacob Luboshitz, Dr Shadan Lelazari, Dr. Jonathan Shapiro, and Dr. Gabi Golan
Fellowship logistics coordinator: Rachel Sinai
Year of IHTC designation: 1993

Areas of specialty: Adult and pediatric hematology; Orthopedic surgery; Nursing; Physiotherapy; Dental care; Laboratory diagnosis (not genetics); Psychology


Location: The INHC is a modern building located at the Sheba Medical Center near Tel-Aviv (15 min. driving distance) and Jerusalem (45 min. driving distance) on the Tel Hashomer campus. There is also the Israeli Central Blood Bank as well as a comprehensive rehabilitation centre.

Climate: The warm season lasts from May 31 to October 15 with an average daily high temperature above 29°C. The cold season lasts from December 9 to March 10 with an average high temperature below 20°C.

Accommodations: There are rooms and cottages available for rental in the campus area.

Language: English and Hebrew


Clinical activities: The Israeli National Hemophilia Center (INHC) is located at the Sheba Medical Center. The hospital is the largest referral centre in the country, which serves a population of over one million. There is a comprehensive institute of thrombosis and hemostasis in addition to the hemophilia centre.

Unique services include: Pediatric Coagulation Service for diagnosis, consultation and treatment of children with hemophilia and other bleeding disorders. Prenatal diagnosis and carrier detection of hemophilia A and B assisted by the laboratories of the Institute of Thrombosis and Hemostasis. Consulting Service for physicians in Israel and worldwide providing solutions for bleeding hemophilia patients or any uncontrolled bleeding in patients with inherited or acquired coagulopathies, as well as trauma cases.

Special techniques developed by the centre (and adopted worldwide) include: Administration of factor replacement concentrates by continuous infusion; development and use of special antifibrinolytic fibrin-sealants; treatment of life-threatening bleeding in trauma patients / surgical patients without pre-existing coagulopathy by recombinant activated factor VII.

Laboratory activities/research: The coagulation laboratory includes both routine and research labs in which the PhDs and the technicians and students work. Routine activities include screening for all bleeding disorders, as well as thrombotic disorders, DNA analysis for hemophilia, vWD, platelet abnormalities and thrombophilic states.

Multidisciplinary activities/research: HIV and hepatitis-related conditions are treated at the INHC as well. Additional services are offered by a social worker, psychologist, physical therapist and genetic counsellor. A comprehensive dental service located at a neighbouring building collaborates closely with our center.

Updated July 2014